ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ivemend 150 mg, Infusionspräparat - Durchstechflasche(n)
57913003 MSD Merck Sharp & Dohme AG
Ivemend 150 mg, Infusionspräparat03.07.2008
  14.03.2011
Aprepitant (A04AD12) 
WHO-DDD 
01.09.Durchstechflasche(n)
01.09. 
B  
Yes 
IP 
58.24Yes
    
10 %79.75
  
7680579130037Synthetika
4884013 
Composition
Praeparatio cryodesiccata: fosaprepitantum 150 mg ut dimeglumini fosaprepitantum, dinatrii edetas, polysorbatum 80, lactosum, pro vitro.
Packungsbestandteile
Praeparatio cryodesiccata:
 
Infusion preparation 
  
 
Active AgentDose
Fosaprepitantum150 mg
BAG: Active AgentDose
Fosaprepitantum150 mg
 
Inactive agents
Dinatrii Edetas
Lactosum
Polysorbatum 80
 
Source
Data was imported : 07.02.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home